CXCR4 expression correlates with the degree of tumor infiltration and BRAF status in papillary thyroid carcinomas
- 1 January 2012
- journal article
- Published by Elsevier in Laboratory Investigation
- Vol. 25 (1) , 46-55
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- The Thyroid Gland: A Crossroad in Inflammation-Induced Carcinoma? An Ongoing Debate with New Therapeutic Potential.Current Medicinal Chemistry, 2010
- Rising Thyroid Cancer Incidence in the United States by Demographic and Tumor Characteristics, 1980-2005Cancer Epidemiology, Biomarkers & Prevention, 2009
- Thyroid carcinoma: molecular pathways and therapeutic targetsLaboratory Investigation, 2008
- CXCR4 Regulates Growth of Both Primary and Metastatic Breast CancerCancer Research, 2004
- The Role of Chemokines in Melanoma Tumor Growth and MetastasisJournal of Investigative Dermatology, 2002
- Involvement of chemokine receptors in breast cancer metastasisNature, 2001
- Prospective multicenter study of thyroid carcinoma treatmentCancer, 1998
- The α-Chemokine, Stromal Cell-derived Factor-1α, Binds to the Transmembrane G-protein-coupled CXCR-4 Receptor and Activates Multiple Signal Transduction PathwaysJournal of Biological Chemistry, 1998
- Chemokines — Chemotactic Cytokines That Mediate InflammationNew England Journal of Medicine, 1998
- Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancerThe American Journal of Medicine, 1994